Revolution Medicines (RVMD) is back in focus after Rasonque received US approval and a positive opinion from Europe’s medicines regulator for adults with metastatic pancreatic adenocarcinoma, which is...
Source LinkRevolution Medicines (RVMD) is back in focus after Rasonque received US approval and a positive opinion from Europe’s medicines regulator for adults with metastatic pancreatic adenocarcinoma, which is...
Source Link
Comments